INTRODUCTION AND OBJECTIVES:
The therapeutic benefit of an extended pelvic lymph node dissection (ePLND) in the surgical treatment of localized prostate cancer is still open for debate. On the other hand, an ePLND is associated with significant additional peri-and postoperative complications, the most frequent one being secondary lymphedema. In this single center prospective analysis, we aim to determine the prevalence, possible risk factors and the effect on quality of life.
METHODS: We have prospectively registered 139 patients who received a robot-assisted radical prostatectomy with ePLND from 2015 to 2018 at our center. Exclusion criteria were conversion to open procedure, salvage cases and follow-up <5mo. CONCLUSIONS: The prevalence of lymphedema after ePLND during radical prostatectomy (20.8 %) is much higher than previously reported. Lymphedema is associated with important effects on the physical and emotional well-being of patients. We confirm adjuvant radiotherapy as a risk factor for the development of lymphedema, whereas age, BMI and symptomatic lymphoceles were not withheld.
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INTRODUCTION AND OBJECTIVES: Lymph node dissection (LND) during radical prostatectomy (RP) for prostate cancer (PCa) aims to provide information for staging and prognosis, while oncological and survival benefits are debatable. The potential harms of LND should be balanced with the benefits on an individual risk assessment.
Given that the eligibility to an eLND is based on the prediction of an aggressive nodal disease, we aimed to explore the actual 5-and 10-years cancer specific survival (CSS) benefit of a LND with the removal of more than 11 nodes on patients with adverse pathological findings (APF) at RP.
METHODS: From the Pathological Registry of Modena (Italy), data on ORP with LND performed since 2000 were retrospectively assessed. Patients with at least 5-and 10-years follow up were considered (1,274 and 581 patients, respectively). APF at RP were recorded as follows: !pT3a in 27.9% and a GS ! 7 in 53.0%. Nodal invasion was evident in 6. 4%(n[82) , and positive surgical margins in 35. 4% (n[451) . The median node yield was similar among organ confined and locally advanced disease (p[0.798) and among GS[ 6 and GS! 7(p[0.392) .
Consistent with previous Literature, we divided the number of nodes removed according to a cut-off point of 11 [ 10 versus !11 (More Extended[ME-LND)]: the correlation between 5-and 10-years CSS and a ME-LND is considered as the primary outcome. Since little is known about the effects of an extended procedure in a pN0 population, the impact of ME-LND on CSS of pN0 with APF at RP is the secondary endpoint.
RESULTS: A ME-LND template was not related to 5-and 10-years CSS in the whole series and in the subgroup with nodal disease (p[ 0.33). Overall, considering pN0 PCa, a 5-years (SHR Vol. 201, No. 4S, Supplement, Sunday, May 5, 2019 THE JOURNAL OF UROLOGY Ò e791
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